References
- Kalmanti L, Saussele S, Lauseker M, Proetel U, Müller MC, Hanfstein B, et al. 2014. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV. Annals of Hematology 93:71–80.
- Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, et al. 2008. The effects of imatinib on pregnancy outcome. Blood 111:5505–5508.
- Tadwalkar S. 2017. The global incidence and prevalence of chronic myeloid leukemia over the next ten years (2017–2027). Journal of Blood Disorders & Transfusion 8:2.
- Yazdani Brojeni P, Matok I, Garcia Bournissen F, Koren G. 2012. A systematic review of the fetal safety of interferon alpha. Reproductive Toxicology (Elmsford, New York) 33:265–268.